Teri Farnsworth, MBA, serves as the Global Human Resources Leader at Terumo Blood and Cell Technologies, where she leverages over 20 years of extensive experience in human capital strategy to drive organizational excellence across diverse industries. In her current role, Teri leads a dynamic team...
Teri Farnsworth, MBA, serves as the Global Human Resources Leader at Terumo Blood and Cell Technologies, where she leverages over 20 years of extensive experience in human capital strategy to drive organizational excellence across diverse industries. In her current role, Teri leads a dynamic team of over 25 HR professionals, dedicated to enhancing the employee experience for more than 5,000 employees spread across key global locations, including Costa Rica, India, Ireland, Vietnam, and the United States. Her strategic oversight encompasses a comprehensive range of HR services that span the entire employee lifecycle, including Benefits, Compensation, Learning & Development, Operations, Talent Acquisition, and Talent Management.
Teri’s expertise as a skilled communicator and change agent has been instrumental in navigating complex transitions, such as organizational expansions and restructurings. She is particularly adept at fostering collaboration among cross-functional teams, ensuring alignment with business objectives while enhancing employee engagement and retention. Her leadership style emphasizes the importance of organizational development and performance management, enabling her to effectively implement high-impact initiatives that drive both individual and organizational success.
Currently, Teri is spearheading several key projects aimed at optimizing HR operations and enhancing talent acquisition strategies, with a focus on creating a more inclusive and diverse workforce. By integrating innovative learning and development programs, she is committed to empowering employees and cultivating a culture of continuous improvement. Teri’s ability to build and maintain strong relationships across all levels of the organization positions her as a pivotal leader in shaping the future of Terumo Blood and Cell Technologies.
